![[HTML version]](/e/graphics/htmlborder.gif)
![[PDF version]](/e/graphics/pdfborder.gif)
![[CIF]](/e/graphics/cifborder.gif)
![[3d view]](/e/graphics/3dviewborder.gif)
![[Structure Factors]](/e/graphics/structurefactorsborder.gif)
![[Supplementary Material]](/e/graphics/supplementarymaterialsborder.gif)
![[CIF check Report]](/e/graphics/checkcifborder.gif)
![[Open access]](/e/graphics/free.gif)
![[Contents scheme]](hy2185contents.gif)
Acta Cryst. (2009). E65, m413-m414 [ doi:10.1107/S1600536809009180 ]
2O1,O1')bis[2-(2-pyridyl)-1H-benzimidazole-
2N2,N3]zinc(II) monohydrateAbstract: In the title compound, [Zn(C8H4O7S)(C12H9N3)2]·H2O, the ZnII atom has a distorted octahedral coordination geometry, defined by four N atoms from two 2-(2-pyridyl)-1H-benzimidazole ligands and two O atoms from a deprotonated carboxylate group of the 3-carboxy-5-sulfonatobenzoate ligand. In the crystal structure, the complex molecules are linked into a three-dimensional network by intermolecular O-H
O and N-H
O hydrogen bonds, and
-
stacking interactions with centroid-centroid separations of 3.758 (2) and 3.597 (1) Å.
Online 19 March 2009
Copyright © International Union of Crystallography
IUCr Webmaster